Origin and development of B1 lymphocytes. A cell population involved in defence and auto-immunity;Origen y desarrollo de linfocitos B1. Una población celular involucrada en defensa y autoinmunidad

Medicina

Volumn 66, Issue 2, 2006, Pages 165-172

  Merino, Maria C ^a   Gruppi, Adriana ^a  

^a UNIVERSIDAD NACIONAL DE CÓRDOBA   (Argentina)

Author keywords

B1 lymphocytes; Natural antibodies; Peritoneal cavity

Indexed keywords

B LYMPHOCYTE ANTIBODY; B LYMPHOCYTE ANTIGEN; IMMUNOGLOBULIN M;

ANTIBODY PRODUCTION; ANTIGEN SPECIFICITY; APOPTOSIS; ARTICLE; AUTOIMMUNITY; B LYMPHOCYTE; B LYMPHOCYTE ACTIVATION; B LYMPHOCYTE DIFFERENTIATION; CELL AGING; CELL MATURATION; CELL SIZE; CYTOPLASM; HUMAN; IMMUNOGLOBULIN PRODUCTION; IMMUNOREGULATION; INFECTION RESISTANCE; LYMPHOCYTE FUNCTION; LYMPHOCYTE SUBPOPULATION; PERITONEAL CAVITY; PHENOTYPE; PLEURA CAVITY;

ANIMALS; ANTIBODIES; ANTIGENS, CD; AUTOIMMUNITY; B-LYMPHOCYTES; HUMANS; IMMUNE SYSTEM; IMMUNITY, CELLULAR; IMMUNOGLOBULINS; PERITONEAL CAVITY;

EID: 33646704279     PISSN: 00257680     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (86)

1. Gitlin D, Hitzig WH, Janeway CA. Multiple serum protein deficiencies in congenital and acquired agammaglobulinemia. J Clin Invest 1956; 35: 1199-204.
2. Ramesh N, Morio T, Fuleihan R, et al. CD40-CD40 ligand (CD40L) interactions and X-linked hyperIgM syndrome (HIGMX-1). Clin Immunol Immunopathol 1995; 76: S208-13.
3. Lipsky PE. Systemic lupus erythematosus: an autoimmune disease of B cell hyperactivity. Nat Immunol 2001; 2: 764-66.
4. Jonsson R, Brokstad KA, Lipsky PE, Zouali M. B-lymphocyte selection and autoimmunity. Trends Immunol 2001; 22: 653-4.
5. Broide DH. Molecular and cellular mechanisms of allergic disease. J Allergy Clin Immunol 2001; 108: S65-71.
6. Calame KL. Plasma cells: finding new light at the end of B cell development. Nat Immunol 2001; 2: 1103-8.
7. Hardy RR, Hayakawa K. B cell development pathways. Annu Rev Immunol 2001; 19: 595-621.
8. Carsetti R, Rosado MM, Wardmann H. Peripheral development of B cells in mouse and man. Immunol Rev 2004; 197: 179-91.
9. Fagarasan S, Honjo T. T-Independent immune response: new aspects of B cell biology. Science 2000; 290: 89-92.
10. Berland R, Wortis HH. Normal B-1a cell development requires B cell-intrinsic NFATc1 activity. Proc Natl Acad Sci U S A 2003; 100: 13459-64.
11. Kroese FG, Ammerlaan WA, Deenen GJ. Location and function of B-cell lineages. Ann N Y Acad Sci 1992; 651: 44-58.
12. Abrahao TB, Freymuller E, Mortara RA, Lopes JD, Mariano M. Morphological characterization of mouse B-1 cells. Immunobiology 2003; 208: 401-11.
13. Berland R, Wortis HH. Origins and functions of B-1 cells with notes on the role of CD5. Annu Rev Immunol 2002; 20: 253-300.
14. Hardy RR, Hayakawa K. CD5 B cells, a fetal B cell lineage. Adv Immunol 1994; 55: 297-339.
15. Kantor AB, Herzenberg LA. Origin of murine B cell lineages. Annu Rev Immunol 1993; 11: 501-38.
16. Fischer GM, Solt LA, Hastings WD, et al. Splenic and peritoneal B-1 cells differ in terms of transcriptional and proliferative features that separate peritoneal B-1 from splenic B-2 cells. Cell Immunol 2001; 213: 62-71.
17. O'Garra A, Chang R, Go N, Hastings R, Haughton G, Howard M. Ly-1 B (B-1) cells are the main source of B cell-derived interleukin 10. Eur J Immunol 1992; 22: 711-17.
18. Ishida H, Hastings R, Kearney J, Howard M. Continuous anti-interleukin 10 antibody administration depletes mice of Ly-1 B cells but not conventional B cells. J Exp Med 1992; 175: 1213-20.
19. Rothstein TL. Cutting edge commentary: two B-1 or not to be one. J Immunol 2002; 168: 4257-61.
20. Cambier JC, Ransom JT. Molecular mechanisms of transmembrane signaling in B lymphocytes. Annu Rev Immunol 1987; 5: 175-99.
21. Klaus GG, O'Garra A, Bijsterbosch MK, Holman M. Activation and proliferation signals in mouse B cells. VIII. Induction of DNA synthesis in B cells by a combination of calcium ionophores and phorbol myristate acetate. Eur J Immunol 1986; 16: 92-7.
22. Rothstein TL, Baeker TR, Miller RA, Kolber DL. Stimulation of murine B cells by the combination of calcium ionophore plus phorbol ester. Cell Immunol 1986; 102: 364-73.
23. Rothstein TL, Kolber DL. Peritoneal B cells respond to phorbol esters in the absence of co-mitogen. J Immunol 1988; 140: 2880-5.
24. Tanguay DA, Colarusso TP, Pavlovic S, et al. Early induction of cyclin D2 expression in phorbol ester-responsive B-1 lymphocytes. J Exp Med 1999; 189: 1685-90.
25. Tanguay DA, Colarusso TP, Doughty C, Pavlovic-Ewers S, Rothstein TL, Chiles TC. Cutting edge: differential signaling requirements for activation of assembled cyclin D3-cdk4 complexes in B-1 and B-2 lymphocyte subsets. J Immunol 2001; 166: 4273-7.
26. Rothstein TL, Kolber DL. Anti-Ig antibody inhibits the phorbol ester-induced stimulation of peritoneal B cells. J Immunol 1988; 141: 4089-93.
27. Morris DL, Rothstein TL. Decreased surface IgM receptor-mediated activation of phospholipase C gamma 2 in B-1 lymphocytes. Int Immunol 1994; 6: 1011-6.
28. Bikah G, Carey J, Ciallella JR, Tarakhovsky A, Bondada S. CD5-mediated negative regulation of antigen receptor-induced growth signals in B-1 B cells. Science 1996; 274: 1906-9.
29. Sen G, Bikah G, Venkataraman C, Bondada S. Negative regulation of antigen receptor-mediated signaling by constitutive association of CD5 with the SHP-1 protein tyrosine phosphatase in B-1 B cells. Eur J Immunol 1999; 29: 3319-28.
30. Ehlich A, Martin V, Muller W, Rajewsky K. Analysis of the B-cell progenitor compartment at the level of single cells. Curr Biol 1994; 4: 573-83.
31. Hardy RR, Carmack CE, Shinton SA, Kemp JD, Hayakawa K. Resolution and characterization of pro-B and pre-pro-B cell stages in normal mouse bone marrow. J Exp Med 1991; 173: 1213-25.
32. Osmond DG. B cell development in the bone marrow. Semin Immunol 1990; 2: 173-80.
33. Rolink A, Melchers F. Generation and regeneration of cells of the B-lymphocyte lineage. Curr Opin Immunol 1993; 5: 207-17.
34. Chung JB, Silverman M, Monroe JG. Transitional B cells: step by step towards immune competence. Trends Immunol 2003; 24: 343-9.
35. Martin F, Kearney JF. B-cell subsets and the mature preimmune repertoire. Marginal zone and B1 B cells as part of a "natural immune memory". Immunol Rev 2000; 175: 70-9.
36. Marsters SA, Yan M, Pitti RM, Haas PE, Dixit VM, Ashkenazi A. Interaction of the TNF homologues BLyS and APRIL with the TNF receptor homologues BCMA and TACI. Curr Biol 2000; 10: 785-8.
37. Wang H, Clarke SH. Positive selection focuses the VH12 B-cell repertoire towards a single B1 specificity with survival function. Immunol Rev 2004; 197: 51-9.
38. Hamilton AM, Lehuen A, Kearney JF. Immuno-fluorescence analysis of B-1 cell ontogeny in the mouse. Int Immunol 1994; 6: 355-61.
39. Herzenberg LA. B-1 cells: the lineage question revisited. Immunol Rev 2000; 175: 9-22.
40. Forster I, Rajewsky K. Expansion and functional activity of Ly-1+ B cells upon transfer of peritoneal cells into allotype-congenic, newborn mice. Eur J Immunol 1987; 17: 521-8.
41. Hayakawa K, Hardy RR, Stall AM, Herzenberg LA. Immunoglobulin-bearing B cells reconstitute and maintain the murine Ly-1 B cell lineage. Eur J Immunol 1986; 16: 1313-6.
42. Hayakawa K, Asano M, Shinton SA, et al. Positive selection of natural autoreactive B cells. Science 1999; 285: 113-6.
43. Hayakawa K, Hardy RR. Development and function of B-1 cells. Curr Opin Immunol 2000; 12: 346-53.
44. Arnold LW, McCray SK, Tatu C, Clarke SH. Identification of a precursor to phosphatidyl choline-specific B-1 cells suggesting that B-1 cells differentiate from splenic conventional B cells in vivo: cyclosporin A blocks differentiation to B-1. J Immunol 2000; 164: 2924-30.
45. Wardemann H, Boehm T, Dear N, Carsetti R. B-1a B cells that link the innate and adaptive immune responses are lacking in the absence of the spleen. J Exp Med 2002; 195: 771-80.
46. Shaw JP, Utz PJ, Durand DB, Toole JJ, Emmel EA, Crabtree GR. Identification of a putative regulator of early T cell activation genes. Science 1988; 241: 202-5.
47. Ho SN, Thomas DJ, Timmerman LA, Li X, Francke U, Crabtree GR. NFATc3, a lymphoid-specific NFATc family member that is calcium-regulated and exhibits distinct DNA binding specificity. J Biol Chem 1995; 270: 19898-907.
48. Timmerman LA, Healy JI, Ho SN, Chen L, Goodnow CC, Crabtree GR. Redundant expression but selective utilization of nuclear factor of activated T cells family members. J Immunol 1997; 159: 2735-40.
49. Verweij CL, Guidos C, Crabtree GR. Cell type specificity and activation requirements for NFAT-1 (nuclear factor of activated T-cells) transcriptional activity determined by a new method using transgenic mice to assay transcriptional activity of an individual nuclear factor. J Biol Chem 1990; 265: 15788-95.
50. Choi MS, Brines RD, Holman MJ, Klaus GG. Induction of NF-AT in normal B lymphocytes by anti-immunoglobulin or CD40 ligand in conjunction with IL-4. Immunity 1994; 1: 179-87.
51. Venkataraman L, Francis DA, Wang Z, Liu J, Rothstein TL, Sen R. Cyclosporin-A sensitive induction of NF-AT in murine B cells. Immunity 1994; 1: 189-96.
52. Berland R, Wortis HH. An NFAT-dependent enhancer is necessary for anti-IgM-mediated induction of murine CD5 expression in primary splenic B cells. J Immunol 1998; 161: 277-85.
53. Foussat A, Balabanian K, Amara A, et al. Production of stromal cell-derived factor 1 by mesothelial cells and effects of this chemokine on peritoneal B lymphocytes. Eur J Immunol 2001; 31: 350-9.
54. Nisitani S, Tsubata T, Murakami M, Honjo T. Administration of interleukin-5 or -10 activates peritoneal B-1 cells and induces autoimmune hemolytic anemia in antierythrocyte autoantibody-transgenic mice. Eur J Immunol 1995; 25: 3047-52.
55. Ishida H, Muchamuel T, Sakaguchi S, Andrade S, Menon S, Howard M. Continuous administration of anti-interleukin 10 antibodies delays onset of autoimmunity in NZB/W F1 mice. J Exp Med 1994; 179: 305-10.
56. Balabanian K, Foussat A, Bouchet-Delbos L, et al. Interleukin-10 modulates the sensitivity of peritoneal B lymphocytes to chemokines with opposite effects on stromal cell-derived factor-1 and B-lymphocyte chemoattractant. Blood 2002; 99: 427-36.
57. Tumang JR, Frances R, Yeo SG, Rothstein TL. Spontaneously Ig-secreting B-1 cells violate the accepted paradigm for expression of differentiation-associated transcription factors. J Immunol 2005; 174: 3173-77.
58. Hayakawa K, Hardy RR, Honda M, Herzenberg LA, Steinberg AD. Ly-1 B cells: functionally distinct lymphocytes that secrete IgM autoantibodies. Proc Natl Acad Sci U S A 1984; 81: 2494-98.
59. Watanabe N, Ikuta K, Fagarasan S, Yazumi S, Chiba T, Honjo T. Migration and differentiation of autoreactive B-1 cells induced by activated gamma/ delta T cells in antierythrocyte immunoglobulin transgenic mice. J Exp Med 2000; 192: 1577-86.
60. Lin KI, Tunyaplin C, Calame K. Transcriptional regulatory cascades controlling plasma cell differentiation. Immunol Rev 2003; 194: 19-28.
61. Calame KL, Lin KI, Tunyaplin C. Regulatory mechanisms that determine the development and function of plasma cells. Annu Rev Immunol 2003; 21: 205-30.
62. Kroese FG, Butcher EC, Stall AM, Lalor PA, Adams S, Herzenberg LA. Many of the IgA producing plasma cells in murine gut are derived from self-replenishing pre-cursors in the peritoneal cavity. Int Immunol 1989; 1: 75-84.
63. Merino C, Montes C, Acosta Rodriguez E, Gruppi A. Phenotype of antibody-secreting cells in the peritoneal cavity of Trypanosoma cruzi infected mice. Book of abstracts VII Latin American Congress of Immunology 2005; 56.
64. Coutinho A, Kazatchkine MD, Avrameas S. Natural autoantibodies. Curr Opin Immunol 1995; 7: 812-8.
65. Briles DE, Forman C, Hudak S, Claflin JL. Anti-phosphorylcholine antibodies of the T15 idiotype are optimally protective against Streptococcus pneumoniae. J Exp Med, 1982; 156: 1177-85.
66. Mi QS, Zhou L, Schulze DH, et al. Highly reduced protection against Streptococcus pneumoniae after deletion of a single heavy chain gene in mouse. Proc Natl Acad Sci U S A 2000;97:6031-6.
67. Boes M, Prodeus AP, Schmidt T, Carroll MC, Chen J. A critical role of natural immunoglobulin M in immediate defense against systemic bacterial infection. J Exp Med 1998; 188: 2381-6.
68. Masmoudi H, Mota-Santos T, Huetz F, Coutinho A, Cazenave PA. All T15 Id-positive antibodies (but not the majority of VHT15+ antibodies) are produced by peritoneal CD5+ B lymphocytes. Int Immunol 1990; 2: 515-20.
69. Mercolino TJ, Arnold LW, Hawkins LA, Haughton G. Normal mouse peritoneum contains a large population of Ly-1+ (CD5) B cells that recognize phosphatidyl choline. Relationship to cells that secrete hemolytic antibody specific for autologous erythrocytes. J Exp Med 1988; 168: 687-98.
70. Binder CJ, Horkko S, Dewan A, et al. Pneumococcal vaccination decreases atherosclerotic lesion formation: molecular mimicry between Streptococcus pneumoniae and oxidized LDL. Nat Med 2003; 9: 736-43.
71. Herzenberg LA, Stall AM, Lalor PA, Sidman C, Moore WA, Parks DR. The Ly-1 B cell lineage. Immunol Rev 1986; 93: 81-102.
72. Dorner T, Brezinschek HP, Foster SJ, Brezinschek RI, Farner NL, Lipsky PE. Comparable impact of mutational and selective influences in shaping the expressed repertoire of peripheral IgM+/CD5- and IgM+/CD5+ B cells. Eur J Immunol 1998; 28: 657-68.
73. Gary-Gouy H, Harriague J, Dalloul A, Donnadieu E, Bismuth G. CD5-negative regulation of B cell receptor signaling pathways originates from tyrosine residue Y429 outside an immunoreceptor tyrosine-based inhibitory motif. J Immunol 2002; 168: 232-9.
74. Gary-Gouy H, Bruhns P, Schmitt C, Dalloul A, Daeron M, Bismuth G. The pseudo- immunoreceptor tyrosine-based activation motif of CD5 mediates its inhibitory action on B-cell receptor signaling. J Biol Chem 2000; 275: 548-56.
75. Hansen K, Singer DB. Asplenic-hyposplenic overwhelming sepsis: postsplenectomy sepsis revisited. Pediatr Dev Pathol 2001; 4: 105-21.
76. Youinou P, Lydyard PM. CD5+ B cells in nonorgan-specific autoimmune diseases: a fresh look. Lupus 2001; 10: 523-5.
77. Manni JA, Guilleron C, Araujo HA. Lymphocyte imbalance in autoimmunity. Medicina (Buenos Aires) 1989; 49: 105-8.
78. Dauphinee M, Tovar Z, Talal N. B cells expressing CD5 are increased in Sjogren's syndrome. Arthritis Rheum 1988; 31: 642-7.
79. Zuckerman E, Slobodin G, Kessel A, et al. Peripheral B-cell CD5 expansion and CD81 overexpression and their association with disease severity and autoimmune markers in chronic hepatitis C virus infection. Clin Exp Immunol 2002; 128: 353-8.
80. Watanabe N, Ikuta K, Nisitani S, Chiba T, Honjo T. Activation and differentiation of autoreactive B-1 cells by interleukin 10 induce autoimmune hemolytic anemia in Fas-deficient antierythrocyte immunoglobulin transgenic mice. J Exp Med 2002; 196: 141-6.
81. Murakami M, Yoshioka H, Shirai T, Tsubata T, Honjo T. Prevention of autoimmune symptoms in autoimmune-prone mice by elimination of B-1 cells. Int Immunol 1995; 7: 877-82.
82. Hippen KL, Tze LE, Behrens TW. CD5 maintains tolerance in anergic B cells. J Exp Med 2000; 191: 883-90.
83. Taki S, Schmitt M, Tarlinton D, Forster I, Rajewsky K. T cell-dependent antibody production by Ly-1 B cells. Ann N Y Acad Sci 1992; 651: 328-35.
84. Forster I, Gu H, Rajewsky K. Germline antibody V regions as determinants of clonal persistence and malignant growth in the B cell compartment. Embo J 1988; 7: 3693-703.
85. Ebeling SB, Schutte ME, Logtenberg T. The majority of human tonsillar CD5+ B cells express somatically mutated V kappa 4 genes. Eur J Immunol 1993; 23: 1405-408.
86. Dono M, Cerruti G, Zupo S. The CD5+ B-cell. Int J Biochem Cell Biol 2004; 36: 2105-11.